Anterior Cruciate Ligament Study
Condition(s) studied
Investigational drug(s) / intervention(s)
Anterior cruciate ligament reconstruction: Anterior cruciate ligament arthroscopic reconstruction
Study summary
This retrospective, prospective observational study aims to evaluate the epidemiology and rate of anterior cruciate ligament re- rupture after surgery in patients treated from January 2020 to December 2030 by recording both clinically and radiographically ligament reconstruction.
The primary outcome is the rate of rupture of the anterior cruciate ligament as measured by the Lachmann test in which a positive value for re-rupture is an anterior translation of the tibia greater than 10mm relative to the femur Secondary Objectives: Verify predisposing factors to anterior cruciate ligament injuries (so anatomical factors such as tibial slope, trochlear groove), demographic factors (age, sex, weight, sports played), and the rate of return to sports, quality of life via questionnaires, and arthrosis at the operated knee
Eligibility
Primary outcome measure(s)
- Rerupture rate — 10 years
rate of rerupture rare evaluated with anterior tibial translation
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS Istituto Ortopedico Galeazzi | Milan | Italy | Recruiting |
More I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06194682 on ClinicalTrials.gov ↗ ← All trials in Italy